DaVita (NYSE:DVA) Reaches New 1-Year High – Time to Buy?

DaVita Inc. (NYSE:DVA)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $179.60 and last traded at $175.61, with a volume of 508351 shares. The stock had previously closed at $176.50.

Wall Street Analyst Weigh In

DVA has been the topic of several research reports. Truist Financial boosted their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Barclays lifted their target price on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $161.80.

DaVita Stock Up 0.5 %

The company has a market capitalization of $14.52 billion, a PE ratio of 19.11, a PEG ratio of 0.86 and a beta of 0.93. The company’s 50 day moving average is $159.72 and its two-hundred day moving average is $155.28. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

Hedge Funds Weigh In On DaVita

Institutional investors have recently bought and sold shares of the stock. Transcendent Capital Group LLC purchased a new position in shares of DaVita in the 3rd quarter worth $25,000. Blue Trust Inc. lifted its holdings in DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock valued at $54,000 after buying an additional 119 shares in the last quarter. Quarry LP bought a new stake in DaVita during the 3rd quarter valued at about $60,000. Venturi Wealth Management LLC lifted its holdings in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after buying an additional 152 shares in the last quarter. Finally, Versant Capital Management Inc lifted its holdings in DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after buying an additional 169 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.